Gene · 10987
Papers2,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MIF modulates p38/ERK phosphorylation via MKP-1 induction in sarcoidosis. | iScience | 2024 | 38299032 | PubTator, text mining | PubMed |
| OTUD7B knockdown inhibits the proliferation and stemness of breast cancer cells by destabilizing FOXM1. | Oncol Lett | 2024 | 38298430 | PubTator, text mining | PubMed |
| Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review. | World J Gastrointest Oncol | 2024 | 38292842 | PubTator, text mining | PubMed |
| Ubiquitin Carboxyl-Terminal Hydrolase L1 and Its Role in Parkinson's Disease. | Int J Mol Sci | 2024 | 38279302 | PubTator, text mining | PubMed |
| Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets. | Cell Commun Signal | 2024 | 38279122 | PubTator, text mining | PubMed |
| SMC5/6 Promotes Replication Fork Stability via Negative Regulation of the COP9 Signalosome. | Int J Mol Sci | 2024 | 38256025 | PubTator, text mining | PubMed |
| Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies. | Pathogens | 2024 | 38251353 | PubTator, text mining | PubMed |
| USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein. | Cancer Cell Int | 2024 | 38229092 | PubTator, text mining | PubMed |
| Deciphering the significance of anoikis in bladder cancer and systematic analysis of S100A7 as a potential therapeutic target. | Eur J Med Res | 2024 | 38217031 | PubTator, text mining | PubMed |
| Non-canonical regulation of the reactivation of an oncogenic herpesvirus by the OTUD4-USP7 deubiquitinases. | PLoS Pathog | 2024 | 38215174 | PubTator, text mining | PubMed |
| Roles of ubiquitin‑specific protease 13 in normal physiology and tumors (Review). | Oncol Lett | 2024 | 38192665 | PubTator, text mining | PubMed |
| Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. | Biomark Res | 2024 | 38191508 | PubTator, text mining | PubMed |
| SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1. | Oncol Rep | 2024 | 38186303 | PubTator, text mining | PubMed |
| MIF contribution to progressive brain diseases. | J Neuroinflammation | 2024 | 38178143 | PubTator, text mining | PubMed |
| Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity. | Signal Transduct Target Ther | 2024 | 38177135 | PubTator, text mining | PubMed |
| Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1. | Nat Commun | 2024 | 38167274 | PubTator, text mining | PubMed |
| Comprehensive characterization of coding and non-coding single nucleotide polymorphisms of the Myoneurin (MYNN) gene using molecular dynamics simulation and docking approaches. | PLoS One | 2024 | 38165846 | PubTator, text mining | PubMed |
| Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells. | Oncol Rep | 2024 | 37975230 | PubTator, text mining | PubMed |
| Extracellular macrophage migration inhibitory factor (MIF) downregulates adipose hormone-sensitive lipase (HSL) and contributes to obesity. | Mol Metab | 2024 | 37935315 | PubTator, text mining | PubMed |
| Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD-L1 in Cancer Therapy. | Adv Sci (Weinh) | 2024 | 37934012 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10987/papers?page=5